-transparent.png){kind=logo}
With the aim of examining central opioid influences on the control of luteinizing hormone (LH) secretion, we evaluated the LH response to naloxone, an opioid receptor antagonist, in patients affected by normo-, hyper-, and hypogonadotropic amenorrhea, polycystic ovarian disease and hyperprolactinemia. The results indicate that opioid influences are altered in well-defined pathologic conditions (hyperprolactinemia, obesity), in addition to being modified by gonadal steroids.
Related Publications
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
October 1989,
Journal of steroid biochemistry,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
February 1989,
Fertility and sterility,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
October 1985,
Fertility and sterility,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
November 1986,
Clinical endocrinology,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
August 1986,
Biology of reproduction,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
March 1987,
The Journal of clinical endocrinology and metabolism,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
August 1999,
Clinical endocrinology,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
March 1979,
Science (New York, N.Y.),
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
September 1986,
Biology of reproduction,
F Petraglia, and
G D'Ambrogio, and
G Comitini, and
F Facchinetti, and
A Volpe, and
A R Genazzani
December 1987,
Endocrinology,
